ArticleCureus2025
Concurrent Tuberculous Meningitis and Toxoplasma Encephalitis in an HIV-Positive Patient: An Exceptionally Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human immunodeficiency virus (HIV) infection is strongly associated with an increased risk of opportunistic infections affecting the central nervous system (CNS). Among these, tuberculous meningitis (TBM) and Toxoplasma encephalitis (TE) represent two of the most frequent and severe infections seen in individuals with advanced immunosuppression. Each condition alone is associated with significant morbidity and mortality, particularly in patients with profoundly diminished CD4+ T-cell counts. While TBM and TE are common individually in the context of HIV/AIDS, their concurrent occurrence within the CNS appears to be exceptionally rare, with only rare or isolated reports in the literature. The co-existence of these infections poses substantial diagnostic and therapeutic challenges due to overlapping clinical manifestations, radiological findings, and the potential for rapid neurological decline. We report a case of a 46-year-old woman with long-standing HIV/AIDS, non-adherent to antiretroviral therapy, who presented with fever, headache, confusion, vomiting, and progressive neurological deficits. Cerebrospinal fluid analysis revealed lymphocytic pleocytosis with low glucose levels and a positive GeneXpert test for Mycobacterium tuberculosis. Toxoplasma IgG was markedly elevated, and brain MRI demonstrated multiple ring-enhancing lesions with surrounding vasogenic edema. Laboratory investigations confirmed advanced immunosuppression, with a declining CD4+ T-cell count and high viral load. She was treated with a combination of anti-tuberculous drugs, corticosteroids, and anti-Toxoplasma therapy. Despite treatment, her neurological condition deteriorated, with residual motor and cognitive deficits at discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.